Screener
aTyr Pharma ATYR Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: aTyr Pharma’s 10-K, filed March 5, 2026.
- Filed
- Mar 5, 2026, 4:11 PM EST
- Fiscal year
- FY2025
- Accession
- 0001339970-26-000008
| Line item | Years Ended December 31, 2025 | Years Ended December 31, 2024 | Years Ended December 31, 2023 |
|---|---|---|---|
| Revenues: | |||
| License and collaboration agreement revenues | $190 | $235 | $353 |
| Total revenues | 190 | 235 | 353 |
| Operating expenses: | |||
| Research and development | 60,219 | 54,372 | 42,293 |
| General and administrative | 17,598 | 13,777 | 12,979 |
| Total operating expenses | 77,817 | 68,149 | 55,272 |
| Loss from operations | (77,627) | (67,914) | (54,919) |
Item 8. Financial Statements and Supplementary Data.
FAQ
- What is aTyr Pharma's total revenue?
- aTyr Pharma (ATYR) reported total revenue of $0 in Q4 2025.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about aTyr Pharma's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude